⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. LONSURF® (trifluridine and tipiracil) tablets just got measured.
4/10 means LONSURF® (trifluridine and tipiracil) tablets is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.
LONSURF is approved for use with or without bevacizumab for patients with previously treated metastatic colorectal cancer. LONSURF is a prescription medicine for patients with colorectal cancer that has spread to other parts of the body and who have previously been treated with chemotherapy medicines. Please see Important Safety Information and full Prescribing Information.
Industry: Healthcare
lonsurf.com2
Structured Data
8
Content Structure
5
Entity Clarity
3
E-E-A-T Signals
6
Technical AEO
2
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
In health and wellness, you're not just selling a product. You're asking someone to trust you with their body.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for LONSURF® (trifluridine and tipiracil) tablets.
Scored by Engagemii on June 28, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/lonsurf
Cite this score: Engagemii (2026). "AEO Score for LONSURF® (trifluridine and tipiracil) tablets." Retrieved from https://engagemii.com/aeo/brands/lonsurf
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform